Pacira BioSciences' Non-Current Assets fell 11.65% to $734.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $734.8 million, marking a year-over-year decrease of 11.65%. This contributed to the annual value of $808.4 million for FY2024, which is 24.05% down from last year.
According to the latest figures from Q3 2025, Pacira BioSciences' Non-Current Assets is $734.8 million, which was down 7.18% from $791.6 million recorded in Q2 2025.
Pacira BioSciences' 5-year Non-Current Assets high stood at $1.2 billion for Q1 2022, and its period low was $533.3 million during Q2 2021.
In the last 3 years, Pacira BioSciences' Non-Current Assets had a median value of $1.0 billion in 2024 and averaged $950.9 million.
In the last 5 years, Pacira BioSciences' Non-Current Assets skyrocketed by 126.49% in 2022 and then decreased by 24.05% in 2024.
Quarterly analysis of 5 years shows Pacira BioSciences' Non-Current Assets stood at $1.2 billion in 2021, then decreased by 2.19% to $1.2 billion in 2022, then decreased by 10.02% to $1.1 billion in 2023, then decreased by 24.05% to $808.4 million in 2024, then decreased by 11.65% to $734.8 million in 2025.
Its Non-Current Assets was $734.8 million in Q3 2025, compared to $791.6 million in Q2 2025 and $826.7 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value